Elanco Animal Health (ELAN) Invested Capital (2017 - 2026)

Elanco Animal Health has disclosed Invested Capital across 10 years of filings, most recently posting $10.5 billion for Q2 2026.

• In Q2 2026, Invested Capital fell 4.35% year-over-year to $10.5 billion; the TTM figure through Jun 2026 stood at $10.5 billion (down 4.35% YoY), while the FY2025 annual figure was $10.6 billion, up 0.98% from the prior year.
• Invested Capital came in at $10.5 billion for Q2 2026 at Elanco Animal Health, roughly flat from $10.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.9 billion in Q1 2023 to a low of $10.5 billion in Q4 2024.
• Average Invested Capital over 5 years is $11.8 billion, with a median of $11.4 billion recorded in 2024.
• Year-over-year, Invested Capital fell 22.52% in 2024 and climbed 4.85% in 2025.
• Over 5 years, Invested Capital stood at $13.5 billion in 2022, then declined by 10.94% to $12.0 billion in 2023, then slipped by 13.08% to $10.5 billion in 2024, then grew by 0.98% to $10.6 billion in 2025, then dropped by 0.55% to $10.5 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $10.5 billion in Q2 2026, $10.5 billion in Q1 2026, and $10.6 billion in Q4 2025.